Altimmune Inc (STU:3G0) Stock News, Headlines & Updates
Altimmune Inc Stock News from GuruFocus
- 1
- 2
May 24, 2024
DEADLINE ALERT for ALT, AXTI, HRBR, and LI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 12:00pm
DEADLINE ALERT for ALT, AXTI, HRBR, LI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 10:00am
May 23, 2024
ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
Marketwired • 5:00pm
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 12:00pm
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
PRNewswire • 5:00am
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PRNewswire • 8:00pm
May 22, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PRNewswire • 1:00pm
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Marketwired • 1:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Marketwired • 10:00am
May 21, 2024
ALT INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Business Wire • 3:00pm
Altimmune, Inc. Sued for Securities Law Violations -- Investors Should Contact Levi & Korsinsky for More Information -- ALT
Marketwired • 2:00pm
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
PRNewswire • 9:00am
The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ALT
PRNewswire • 5:00am
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 3:00am
May 20, 2024
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 5:00pm
Robbins LLP Urges Altimmune, Inc. (ALT) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Business Wire • 3:00pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines -- ALT
Marketwired • 11:00am
May 17, 2024
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- ALT
Marketwired • 6:00pm
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 5, 2024 -- ALT
Marketwired • 1:00pm
DEADLINE ALERT for ALT, AXTI, HRBR, and LI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Marketwired • 12:00pm
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Marketwired • 10:00am
May 16, 2024
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
PRNewswire • 4:01pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
PRNewswire • 12:00pm
Investors who lost money on Altimmune, Inc. (ALT) should contact The Gross Law Firm about pending Class Action - ALT
Marketwired • 12:00pm
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
PRNewswire • 10:00pm
May 15, 2024
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Business Wire • 2:00pm
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALT
PRNewswire • 5:00am
May 14, 2024
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
Business Wire • 1:00pm
Shareholders of Altimmune, Inc. Should Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights -- ALT
Marketwired • 12:00pm
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Marketwired • 3:00am
May 13, 2024
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors
Business Wire • 12:00pm
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PRNewswire • 6:00am
May 12, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines -- ALT
Marketwired • 1:00pm
May 11, 2024
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
Business Wire • 9:00pm
May 10, 2024
Altimmune Inc (ALT) Reports Q1 2024 Financials: A Detailed Review
GuruFocus Research • 12:53pm
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit -- ALT
Marketwired • 12:00pm
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors
Business Wire • 12:00pm
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc.(ALT) Shareholders
PRNewswire • 5:00am
May 09, 2024
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers